BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18541139)

  • 21. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L
    Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity.
    Krag MB; Nielsen S; Guo Z; Pedersen SB; Schmitz O; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):452-61. PubMed ID: 18331610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
    Wang ZJ; Liu Q; Li PP; Zou CH; Shen ZF
    Eur J Pharmacol; 2008 Feb; 580(1-2):277-83. PubMed ID: 18048028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet.
    Baranowski M; Błachnio A; Zabielski P; Górski J
    J Physiol Pharmacol; 2007 Mar; 58(1):57-72. PubMed ID: 17440226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term pioglitazone treatment enhances lipolysis in rat adipose tissue.
    Pravenec M; Kazdová L; Maxová M; Zídek V; Mlejnek P; Simáková M; Kurtz TW
    Int J Obes (Lond); 2008 Dec; 32(12):1848-53. PubMed ID: 18936763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats.
    Kim HJ; Zhao ZS; Lee YJ; Shim WS; Kim SK; Ahn CW; Park CW; Lee HC; Cha BS
    Diabetes Obes Metab; 2006 Mar; 8(2):175-83. PubMed ID: 16448521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pioglitazone on high-fat-diet-induced ventricular remodeling and dysfunction in rats.
    Tian YQ; Li SS; Su XD; Zhang GZ; Zhao JJ; Li GW; Wang L
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):223-8. PubMed ID: 22031275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diet compounds, glycemic index and obesity-related cardiac effects.
    Diniz YS; Burneiko RM; Seiva FR; Almeida FQ; Galhardi CM; Filho JL; Mani F; Novelli EL
    Int J Cardiol; 2008 Feb; 124(1):92-9. PubMed ID: 17383755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
    Ghanaat-Pour H; Sjöholm A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive dahl salt-sensitive rat.
    Okere IC; Chess DJ; McElfresh TA; Johnson J; Rennison J; Ernsberger P; Hoit BD; Chandler MP; Stanley WC
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):825-31. PubMed ID: 16173943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of metabolic intervention on substrate metabolism in the human heart.
    Kaijser L
    Adv Myocardiol; 1980; 2():51-9. PubMed ID: 7423062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids.
    Stavinoha MA; Rayspellicy JW; Hart-Sailors ML; Mersmann HJ; Bray MS; Young ME
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E878-87. PubMed ID: 15292029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.
    Yamagishi S; Ogasawara S; Mizukami H; Yajima N; Wada R; Sugawara A; Yagihashi S
    J Neurochem; 2008 Jan; 104(2):491-9. PubMed ID: 17995925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-α and free fatty acids.
    El-Moselhy MA; Taye A; Sharkawi SS; El-Sisi SF; Ahmed AF
    Food Chem Toxicol; 2011 May; 49(5):1129-40. PubMed ID: 21310207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of maternal dietary treatments with natural PPAR ligands on lipid metabolism in fetuses from control and diabetic rats.
    Capobianco E; Martínez N; Higa R; White V; Jawerbaum A
    Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):191-9. PubMed ID: 18947987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats.
    Yadav H; Jain S; Yadav M; Sinha PR; Prasad GB; Marotta F
    Dig Liver Dis; 2009 Jul; 41(7):500-8. PubMed ID: 19196556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
    Akki A; Seymour AM
    Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.